Einsatz der Magnetresonanz-Mammographie jenseits der Differenzialdiagnose von malignen und benignen Befunden: Ist eine Vorhersage von Lymphknotenmetasten möglich?
Matthias Dietzel(Friedrich-Alexander-Universität Erlangen-Nürnberg), WA Kaiser(Jena University Hospital), Tobias Gröschel(Friedrich Schiller University Jena), H Habrecht(Center for Clinical Studies), Pascal Baltzer(Medical University of Vienna), Oumar Camara(Friedrich Schiller University Jena), R Zoubi(Friedrich Schiller University Jena), Mieczysław Gajda(Friedrich Schiller University Jena)
RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
April 1, 2011
Cited by 0
Related Papers
METhodological RadiomICs Score (METRICS): a quality scoring tool for radiomics research endorsed by EuSoMII
|Insights into Imaging|2024|286
Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients
|Investigative Radiology|2018|278
Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)
|Breast Cancer Research and Treatment|2018|251
False-Positive Findings at Contrast-Enhanced Breast MRI: A BI-RADS Descriptor Study
|American Journal of Roentgenology|2010|197
Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping for Breast Cancer Detection as a Stand-Alone Parameter
|Investigative Radiology|2018|161